Evidence map›Paper›PMID 39983721›Full record

ArticleDevelopmental cell2025

TGF-β signaling controls neural crest developmental plasticity via SMAD2/3.

Megan Rothstein, Ana Paula Azambuja, Tatiane Y Kanno, Catriona Breen, Marcos Simoes-Costa

Abstract read
In one paragraph

Article in Developmental cell, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Megan RothsteinDepartment of Molecular Biology and Genetics, Cornell University, Ithaca, NY, USA.
Ana Paula AzambujaDepartment of Systems Biology, Harvard Medical School, Boston, MA, USA; Department of Pathology, Boston Children's Hospital, Boston, MA, USA; Department of Molecular Biology and Genetics, Cornell University, Ithaca, NY, USA.
Tatiane Y KannoDepartment of Systems Biology, Harvard Medical School, Boston, MA, USA; Department of Pathology, Boston Children's Hospital, Boston, MA, USA; Department of Molecular Biology and Genetics, Cornell University, Ithaca, NY, USA.
Catriona BreenDepartment of Molecular Biology and Genetics, Cornell University, Ithaca, NY, USA.
Marcos Simoes-CostaDepartment of Systems Biology, Harvard Medical School, Boston, MA, USA; Department of Pathology, Boston Children's Hospital, Boston, MA, USA; Department of Molecular Biology and Genetics, Cornell University, Ithaca, NY, USA. Electronic address: marcos@hms.harvard.edu.

Funding

Genomic control of neural crest identity by signaling systemsR01DE028576 · NIDCR · CORNELL UNIVERSITY · PI SIMOES-COSTA, MARCOS · 2019 to 2023
$1.9M
Epigenomic control of the neural crest cis-regulatory landscape by TGF-beta signalingF99DE030326 · NIDCR · CORNELL UNIVERSITY · PI ROTHSTEIN, MEGAN · 2021 to 2022
$77k
NIDCR NIH HHS F99 DE030326NIDCR NIH HHS R01 DE028576
6 · The paper itself

Abstract

The neural crest is a highly plastic stem cell population that represents an exception to the germ layer theory. Despite being of ectodermal origin, cranial neural crest cells can differentiate into skeletal derivatives typically formed by mesoderm. Here, we report that SMAD2/3-mediated transforming growth factor β (TGF-β) signaling enhances neural crest developmental potential in the chicken embryo. Our results show that TGF-β signaling modulates neural crest axial identity and directly controls the gene circuits that support skeletal differentiation. Cooperation between TGF-β and low levels of WNT signaling in the embryonic head activates cranial-specific cis-regulatory elements. Activation of TGF-β signaling reprogrammed trunk neural crest cells into adopting an anterior identity and led to the development of an improved protocol for the generation of human cranial neural crest cells. Our findings indicate TGF-β signaling is required for the specification of cranial neural crest cells, endowing them with the potential to give rise to the craniofacial skeleton.

Indexed as

Neural CrestSignal TransductionSmad2 ProteinSmad3 ProteinTransforming Growth Factor betaAnimalsCell DifferentiationChick EmbryoGene Expression Regulation, DevelopmentalHumansWnt Signaling PathwaySmad2 ProteinSmad3 ProteinTransforming Growth Factor beta

Identifiers

PMID39983721
PMCPMC12187560

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.